Phase II data for entinostat, a class 1 selective histone deacetylase inhibitor, in patients whose breast cancer is progressing on aromatase inhibitor therapy.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 1052-1052 ◽  
Author(s):  
A. M. Wardley ◽  
R. Stein ◽  
J. McCaffrey ◽  
J. Crown ◽  
Z. Malik ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Aromatase Inhibitor ◽  
Histone Deacetylase ◽  
Phase Ii ◽  
Histone Deacetylase Inhibitor ◽  
Inhibitor Therapy ◽  
Aromatase Inhibitor Therapy ◽  
Deacetylase Inhibitor ◽  
Class 1

A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 559-559
Author(s):  
T. Cigler ◽  
M. J. Higgins ◽  
J. Szymonifka ◽  
A. H. Partridge ◽  
J. A. Ligibel ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Aromatase Inhibitor ◽  
Phase Ii ◽  
Drug Withdrawal ◽  
Inhibitor Therapy ◽  
Phase Ii Clinical Trial ◽  
Aromatase Inhibitor Therapy
Sign in / Sign up

Export Citation Format

Share Document